AstraZeneca Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio28.8835.1463.701625.3141.07
P/S Ratio3.764.574.724.874.93
P/B Ratio4.975.345.654.638.39
Price/FCF20.4523.2924.0337.3634.20
Price/OCF17.1320.2321.3530.5327.35
Enterprise Value Ratios
EV/Revenue4.225.135.385.605.63
EV/EBITDA12.9916.5117.3431.2721.44
EV/EBIT17.6524.3427.0572.3234.29
EV/FCF22.9626.1427.3543.0139.04
Profitability & Returns
Return on Equity (ROE)0.18%0.16%0.09%0.00%0.21%
Return on Assets (ROA)0.08%0.06%0.05%0.02%0.04%
Return on Invested Capital (ROIC)0.16%0.13%0.14%0.06%0.12%
Return on Capital Employed (ROCE)0.17%0.14%0.13%0.04%0.09%
Leverage & Solvency Ratios
Debt/Equity0.740.760.840.851.45
Debt/EBITDA1.702.042.234.813.15
Debt/FCF3.063.303.576.855.92
Liquidity Ratios
Current Ratio0.930.820.861.160.96
Quick Ratio0.670.580.610.670.67
Efficiency Ratios
Asset Turnover0.530.460.440.430.42
Inventory Turnover1.801.591.261.851.45
Yield & Distribution Ratios
Earnings Yield0.03%0.03%0.02%0.00%0.02%
FCF Yield0.05%0.04%0.04%0.03%0.03%
Dividend Yield0.02%0.02%0.02%0.03%0.03%
Payout Ratio0.66%0.75%1.33%34.43%1.12%
Buyback Yield0.00%0.00%-0.09%-0.09%-0.01%
Total Return0.02%0.02%-0.07%-0.06%0.02%